Prøve GULL - Gratis

PPPs Transforming Chronic Diseases Burden Among Indian Women

Bio Spectrum

|

March 2025

More and more Indian health research institutions and the World Health Organization (WHO) are realising that medical interventions alone are insufficient to alleviate the burden of chronic diseases among women.

- Prof. (Dr) Dorairaj Prabhakaran

PPPs Transforming Chronic Diseases Burden Among Indian Women

Economic empowerment, extensive social reforms, and a radical rethinking of women's health as a vital national priority are all demanded. The public-private partnerships (PPPs) that combine medical science, social policy, and community involvement are the most promising method to bring about significant change. The PPPs' capacity to transform healthcare by developing accessible, reasonably priced interventions has been continuously demonstrated.

Communities and countries and ultimately the world are only as strong as their women's health."

– Michelle Obama

The upsurge in chronic diseases such as diabetes, heart and lung diseases, and cancer portends a potential healthcare catastrophe of significant magnitude, with women bearing a disproportionate burden of this unfolding scenario. The burden of chronic diseases among women in India represents a critical public health challenge, with cardiovascular diseases (CVD) or heart diseases and cancers emerging as health concerns. Addressing this crisis in India demands a comprehensive, collaborative approach that leverages public-private partnerships across multiple sectors.

India can develop relevant and scalable solutions by fostering innovative alliances between government agencies, healthcare providers, research institutions, civil society organisations, and private sector partners. These alliances can play a pivotal role in driving targeted health interventions, enabling widespread access to quality care. By focusing on preventive measures and integrating communitydriven insights, such collaborations can ensure that healthcare initiatives are responsive to the specific needs of women across diverse socio-economic and geographical contexts.

Need for Innovative Solutions

Bio Spectrum

Denne historien er fra March 2025-utgaven av Bio Spectrum.

Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.

Allerede abonnent?

FLERE HISTORIER FRA Bio Spectrum

Bio Spectrum

Bio Spectrum

WHO certifies Suriname malaria-free

Suriname became the first country in the Amazon region to receive malaria-free certification from the World Health Organization (WHO).

time to read

1 min

August 2025

Bio Spectrum

Bio Spectrum

Torrent Pharma buys controlling stake in JB Pharma from KKR for Rs 25,689 Cr valuation

Ahmedabad-based Torrent Pharmaceuticals and global investment firm KKR have announced that Torrent has entered into definitive agreements to acquire controlling stake in Mumbai-based J. B. Chemicals and Pharmaceuticals (JB Pharma) from KKR at an Equity Valuation of Rs 25,689 crore (on fully diluted basis), followed by a merger of the two entities.

time to read

1 min

August 2025

Bio Spectrum

Suraksha Diagnostics injects Rs 22 Cr to establish Eastern India's largest genomics lab

Suraksha Diagnostics, one of the leading diagnostics chains in Eastern India, has launched one of the largest and a state-of-theart genomics lab in Eastern India.

time to read

1 min

August 2025

Bio Spectrum

Illumina buys SomaLogic for $425 M to accelerate proteomics business

Illumina, Inc. has entered into a definitive agreement with Standard BioTools under which Illumina will acquire SomaLogic, a leader in data-driven proteomics technology, and other specified assets for $350 million in cash payable at closing, subject to customary adjustments, plus up to $75 million in near-term performance-based milestones and performance-based royalties.

time to read

1 min

August 2025

Bio Spectrum

Bio Spectrum

Kashmik Formulation to expand capacity, eyes Rs 100 Cr revenue in FY26

Kashmik Formulation, a pharmaceutical manufacturing company headquartered in Ahmedabad, has announced significant expansion plans aimed at increasing production capacity, strengthening its presence in international markets, and enhancing operational efficiencies through automation.

time to read

1 min

August 2025

Bio Spectrum

WHO highlights risks associated with use of semaglutide medicines

The World Health Organisation (WHO) is alerting healthcare professionals and regulatory authorities to the risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with the use of semaglutide medicinesOzempic, Rybelsus, and Wegovy.

time to read

1 min

August 2025

Bio Spectrum

Bio Spectrum

Lamark Biotech secures Rs 6.5 Cr to accelerate development of thermostable insulin

Lamark Biotech, an innovation-led biopharma startup, has raised Rs 6.5 crore in a PreSeries A round led by IAN Group, including IAN Alpha Fund, powered by BioAngels, Dr Vinayender Tulla, Dr Nita Roy, and Venkataraman KNK, domain experts of IAN's angel investors led the round.

time to read

1 min

August 2025

Bio Spectrum

Bio Spectrum

AstraZeneca invests Rs 166 Cr to expand Global Hub in Bengaluru

AstraZeneca, a global, science-led biopharmaceutical company, has announced the expansion of its state-of-the-art Global Hub in Bengaluru, strengthening its presence in India.

time to read

1 min

August 2025

Bio Spectrum

Bio Spectrum

Novo Nordisk launches injectable Semaglutide for weight management in India

Novo Nordisk, a leading global healthcare company headquartered in Denmark with over a 100-year legacy of chronic disease care, has announced the launch of Wegovy (injectable Semaglutide) in India.

time to read

1 min

August 2025

Bio Spectrum

Bio Spectrum

Can Policy Reforms & Investments Trigger India's MedTech MAKEOVER?

India's MedTech sector has long been import-dependent. The Centre is now working to change this by positioning the country as an export-oriented manufacturing hub. A series of policies and investments have been introduced to support this shift. Have these made an impact? What steps are necessary to strengthen India's position in the global medical technology (MedTech) landscape? Let's find out.

time to read

12 mins

August 2025

Listen

Translate

Share

-
+

Change font size